UCLA research could lead to a simple saliva test capable of diagnosing — at an early stage — diabetes and cancer, and perhaps neurological disorders and autoimmune diseases.
The study, the most comprehensive analysis ever conducted of RNA molecules in human saliva, reveals that saliva contains many of the same disease-revealing molecules that are contained in blood. It was published online today by the peer-reviewed journal Clinical Chemistry and will be published in the journal’s January 2015 special print issue, “Molecular Diagnostics: A Revolution in Progress.”
“If we can define the boundaries of molecular targets in saliva, then we can ask what the constituents in saliva are that can mark someone who has pre-diabetes or the early stages of oral cancer or pancreatic cancer — and we can utilize this knowledge for personalized medicine,” said Dr. David Wong, a senior author of the research and UCLA’s Felix and Mildred Yip Endowed Professor in Dentistry.
Wong said the test also holds promise for diagnosing Type 2 diabetes, gastric cancer and other diseases. “If you don’t look in saliva, you may miss important indicators of disease,” Wong said. “There seems to be treasure in saliva, which will surprise people.”
RNA, widely known as a cellular messenger that makes proteins and carries out DNA’s instructions to other parts of the cell, is now understood to perform sophisticated chemical reactions and is believed to perform an extraordinary number of other functions, at least some of which are unknown.
Wong’s research over the past decade has focused on identifying biomarkers in saliva. His laboratory discovered that some of the same RNA that is inside human cells are also present in saliva and can be used to detect diseases — a surprising finding, he said, because enzymes in saliva can degrade RNA, making the mouth “a hostile environment.”
The new research is a collaboration with Xinshu (Grace) Xiao, the paper’s other senior author and a UCLA associate professor of integrative biology and physiology in the UCLA College. Using state-of-the-science genomics and bioinformatics, the researchers analyzed 165 million genetic sequences.
Among the many forms of RNA are some unusual ones that live in the mouth and in cells. For example, it wasn’t known until very recently that RNA comes in a circular form; the linear form has long been known. But the UCLA scientists identified more than 400 circular RNAs in human saliva — the first discovery of circular RNA in saliva or any body fluid — including 327 forms that were previously unknown.
Circular RNA’s function in saliva is not entirely understood, although it does serve as a sponge for tiny RNA molecules called microRNAs, which bind to it.
“Circular RNAs in saliva may be protecting other RNAs,” said Xiao, who also is a member of UCLA’s Molecular Biology Institute. It’s likely, she said, that circular RNAs in saliva protect microRNAs from being degraded.
MicroRNAs, which once seemed to be little more than molecular noise, play important roles in many cell types, and have been implicated in cancers and other diseases, Xiao said. One microRNA can regulate hundreds of genes, she said.
The scientists compared microRNA levels in saliva to those in the blood and other body fluids, and found the levels of microRNA in blood and in saliva are very similar — indicating that a saliva sample would be a good measure of microRNAs in the body.
They also found that saliva contains another class of small RNAs, called piwi-interacting RNAs, or piRNAs, which are produced by stem cells, skin cells and germ cells. There are very few piRNAs in blood and most other body fluids, but Xiao’s analysis showed that piRNA are abundant in saliva. Although their function is not yet known, Xiao said they may protect the body from viral infection.
While most RNA molecules translate genetic code from DNA to make proteins, there is also a class called non-coding RNAs that does not.
“Saliva carries with it non-coding RNAs, microRNAs, piRNAs and circRNAs that are biomarkers for disease and health monitoring,” said Wong, who also is associate dean of research at the UCLA School of Dentistry. “Had we not done this collaboration, we would never know that non-coding RNAs, microRNAs, piRNAs and circRNAs exist in saliva.”
Their overriding conclusion is that saliva has tremendous medical and scientific value. In the not-too-distant future, dentists might be able to take saliva samples to analyze for a variety of diseases. And, Wong says, the research could lead to a new category of self-diagnostic devices. “This could indicate that wearable gear that informs you whether you have a disease — even before you have any symptoms — is almost here,” he said.
The Latest on: Molecular diagnostics
via Google News
The Latest on: Molecular diagnostics
- Sepsis Diagnostics Market Growing at CAGR of 9.1% from 2018-2023 | Driver, Restraint, Leading Companieson February 21, 2020 at 4:35 pm
The global sepsis diagnostics market is projected to reach USD 613.9 million by 2023 from USD 396.6 million in 2018, at a CAGR of 9.1%. “bioMérieux (France), Becton, Dickinson, and Company (US), and ...
- RSV Diagnostics Market is Booming with Strong Growth Prospects| Sekisui diagnostics, Luminex, Hologicon February 21, 2020 at 8:47 am
This intelligence report provides a comprehensive analysis of the "Global RSV Diagnostics Market. This includes Investigation of past progress, ongoing market scenarios, and future prospects. Data ...
- Molecular Cancer Diagnostics Market Insights, 2019 to 2025 - Industry Developments, Technologies, Products, Regions, and Competitorson February 21, 2020 at 3:53 am
DUBLIN, Feb. 21, 2020 /PRNewswire/ -- The "Molecular Cancer Diagnostics Market" report has been added to ResearchAndMarkets.com's offering. This report contains market sizing and forecasts for this ...
- Molecular Cancer Diagnostics Industry Overview and Forecast to 2025on February 21, 2020 at 12:58 am
Dublin, Feb. 21, 2020 (GLOBE NEWSWIRE) -- The "Molecular Cancer Diagnostics Market" report has been added to ResearchAndMarkets.com's offering. This report contains market sizing and forecasts for ...
- Improved PCR Flu Diagnostic for Pandemic Response: Interview with Chris Hole of TTPon February 20, 2020 at 1:33 pm
The company claims that the system, which uses a high speed version of traditional RT-PCR (reverse transcription polymerase chain reaction), incorporates several breakthroughs that translate to ...
- Co-Diagnostics Completes Submission of CE Marking Registration for COVID-19 Coronavirus Teston February 20, 2020 at 11:50 am
SALT LAKE CITY--(BUSINESS WIRE)--Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced ...
- Molecular-based Cancer Diagnostic Market Reaches $1.6 Billionon February 20, 2020 at 12:30 am
ARLINGTON, Va., Feb. 19, 2020 Cancer diagnostics is a highly dynamic field that consists of various types of platforms. Molecular diagnostics platforms are increasingly becoming popular as they enable ...
- Global Transplant Diagnostics Market Expected to Grow with a CAGR of 6% Over the Forecast Period, 2019-2025 - ResearchAndMarkets.comon February 19, 2020 at 9:11 am
For more information about this report visit https://www.researchandmarkets.com/r/v245dk ...
- HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conferenceon February 19, 2020 at 5:34 am
TUCSON, Ariz., Feb. 19, 2020 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that John ...
- BRIEF-Alphahelix Molecular Diagnostics Q4 Loss After Tax Narrows To SEK 0.6 Millionon February 17, 2020 at 8:31 am
Our Standards:The Thomson Reuters Trust Principles.
via Bing News